Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2019, Article ID 5129526, 12 pages
https://doi.org/10.1155/2019/5129526
Review Article

Potential for Isolation of Immortalized Hepatocyte Cell Lines by Liver-Directed In Vivo Gene Delivery of Transposons in Mice

1Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima 890-8544, Japan
2Division of Pediatric Dentistry, Graduate School of Medical and Dental Science, Niigata University, Niigata 951-8514, Japan
3Department of Pediatric Dentistry, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan
4Division of Biomedical Engineering, National Defense Medical College Research Institute, Saitama 359-8513, Japan
5Animal Genome Unit, Institute of Livestock and Grassland Science, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki 305-0901, Japan

Correspondence should be addressed to Masahiro Sato; pj.ca.u-amihsogak.mfuk.m@otasasam

Received 9 March 2019; Accepted 6 May 2019; Published 2 June 2019

Guest Editor: Luis E. Gomez-Quiroz

Copyright © 2019 Masahiro Sato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. W. Masters, “Human cancer cell lines: fact and fantasy,” Nature Reviews Molecular Cell Biology, vol. 1, no. 3, pp. 233–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Stewart and R. A. Weinberg, “Senescence: does it all happen at the ends?” Oncogene, vol. 21, no. 4, pp. 627–630, 2002. View at Publisher · View at Google Scholar
  3. S. A. Stewart and R. A. Weinberg, “Telomeres: cancer to human aging,” Annual Review of Cell and Developmental Biology, vol. 22, no. 1, pp. 531–557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. S. H. Ali and J. A. DeCaprio, “Cellular transformation by SV40 large T antigen: interaction with host proteins,” Seminars in Cancer Biology, vol. 11, no. 1, pp. 15–23, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. Bodnar, M. Ouellette, M. Frolkis et al., “Extension of life-span by introduction of telomerase into normal human cells,” Science, vol. 279, no. 5349, pp. 349–352, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Zhu, H. Wang, J. M. Bishop, and E. H. Blackburn, “Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 7, pp. 3723–3728, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Lundberg, W. C. Hahn, P. Gupta, and R. A. Weinberg, “Genes involved in senescence and immortalization,” Current Opinion in Cell Biology, vol. 12, no. 6, pp. 705–709, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Yanai, T. Satoh, S. Kyo, K. Abe, M. Suzuki, and M. Masuo, “A tubule cell line established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene,” Japanese Journal of Cancer Research, vol. 82, no. 12, pp. 1344–1348, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Yanai, M. Suzuki, and M. Obinata, “Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene,” Experimental Cell Research, vol. 197, no. 1, pp. 50–56, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Obinata, “The immortalized cell lines with differentiation potentials: their establishment and possible application,” Cancer Science, vol. 98, no. 3, pp. 275–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Tsukada, Y. Tomooka, S. Takai et al., “Enhanced proliferative potential in culture of cells from p53-deficient mice,” Oncogene, vol. 8, pp. 3313–3322, 1993. View at Google Scholar
  12. H. J. Moshage, H. J. W. de Haard, H. M. G. Princen, and S. H. Yap, “The influence of glucocorticoid on albumin synthesis and its messenger RNA in rat in vivo and in hepatocyte suspension culture,” Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol. 824, no. 1, pp. 27–33, 1985. View at Publisher · View at Google Scholar · View at Scopus
  13. C. R. W. Padgham, C. C. Boyle, X. J. Wang, S. M. Raleigh, M. C. Wright, and A. J. Paine, “Alteration of transcription factor mRNAs during the isolation and culture of rat hepatocytes suggests the activation of a proliferative mode underlies their dedifferentiation,” Biochemical and Biophysical Research Communications, vol. 197, no. 2, pp. 599–605, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Gripon, S. Rumin, S. Urban et al., “Infection of a human hepatoma cell line by hepatitis B virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15655–15660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. W. Colby and T. Shenk, “Fragments of the simian virus 40 transforming gene facilitate transformation of rat embryo cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 17, pp. 5189–5193, 1982. View at Publisher · View at Google Scholar · View at Scopus
  16. C. D. Woodworth and H. C. Isom, “Transformation of differentiated rat hepatocytes with adenovirus and adenovirus DNA,” Journal of Virology, vol. 61, no. 11, pp. 3570–3579, 1987. View at Google Scholar
  17. D. Paul, M. Höhne, and B. Hoffmann, “Immortalization and malignant transformation of hepatocytes by transforming genes of polyoma virus and of SV40 virus in vitro and in vivo,” Wiener klinische Wochenschrift, vol. 66, pp. 134–139, 1988. View at Google Scholar
  18. S. Chen and E. Paucha, “Identification of a region of simian virus 40 large T antigen required for cell transformation,” Journal of Virology, vol. 64, no. 7, pp. 3350–3357, 1990. View at Google Scholar
  19. N. Watanabe, H. Odagiri, E. Totsuka, and M. Sasaki, “A new method to immortalize primary cultured rat hepatocytes,” Transplantation Proceedings, vol. 36, no. 8, pp. 2457–2461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Woodworth, T. Secott, and H. C. Isom, “Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells,” Cancer Research, vol. 46, no. 8, pp. 4018–4026, 1986. View at Google Scholar
  21. C. D. Woodworth, J. W. Kreider, L. Mengel, T. Miller, Y. L. Meng, and H. C. Isom, “Tumorigenicity of simian virus 40-hepatocyte cell lines: effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes,” Molecular and Cellular Biology, vol. 8, no. 10, pp. 4492–4501, 1988. View at Publisher · View at Google Scholar · View at Scopus
  22. C. D. Woodworth and H. C. Isom, “Immortalized hepatocytes as in vitro model systems for toxicity testing: the comparative toxicity of menadione in immortalized cells, primary cultures of hepatocytes and HTC hepatoma cells,” Toxicology in Vitro, vol. 10, no. 6, pp. 721–727, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Macdonald and B. Willett, “The immortalisation of rat hepatocytes by transfection with SV40 sequences,” Cytotechnology, vol. 23, no. 1/3, pp. 161–170, 1997. View at Publisher · View at Google Scholar
  24. A. Werner, S. Duvar, J. Müthing et al., “Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system,” Annals of the New York Academy of Sciences, vol. 875, no. 1, pp. 364–368, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Fukaya, S. Asahi, S. Nagamori et al., “Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT,” In Vitro Cellular & Developmental Biology - Animal, vol. 37, no. 5, pp. 266–269, 2001. View at Publisher · View at Google Scholar
  26. N. Kobayashi, H. Noguchi, T. Watanabe et al., “Role of immortalized hepatocyte transplantation in acute liver failure,” Transplantation Proceedings, vol. 33, no. 1-2, pp. 645-646, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Li, L. J. Li, H. C. Cao et al., “Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy,” ASAIO Journal, vol. 51, no. 3, pp. 262–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Werness, A. Levine, and P. Howley, “Association of human papillomavirus types 16 and 18 E6 proteins with p53,” Science, vol. 248, no. 4951, pp. 76–79, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Münger, B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley, “Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product,” The EMBO Journal, vol. 8, no. 13, pp. 4099–4105, 1989. View at Publisher · View at Google Scholar
  30. C. P. Morales, S. E. Holt, M. Ouellette et al., “Absence of cancer–associated changes in human fibroblasts immortalized with telomerase,” Nature Genetics, vol. 21, no. 1, pp. 115–118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Zhou, D. Ding, M. Wang, and Y. S. Cong, “Telomerase reverse transcriptase in the regulation of gene expression,” BMB Reports, vol. 47, no. 1, pp. 8–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Pfeifer, K. E. Cole, D. T. Smoot et al., “Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 11, pp. 5123–5127, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. B. H. Kim, S. R. Sung, E. H. Choi et al., “Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage,” Experimental & Molecular Medicine, vol. 32, no. 1, pp. 29–37, 2000. View at Publisher · View at Google Scholar
  34. N. Kobayashi, T. Fujiwara, K. A. Westerman et al., “Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes,” Science, vol. 287, no. 5456, pp. 1258–1262, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Kobayashi, H. Noguchi, T. Fujiwara, K. A. Westerman, P. Leboulch, and N. Tanaka, “Establishment of a highly differentiated immortalized adult human hepatocyte cell line by retroviral gene transfer,” Transplantation Proceedings, vol. 32, no. 7, pp. 2368-2369, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Smalley, K. Leiper, R. Tootle, P. Mccloskey, M. J. O'Hare, and H. Hodgson, “Immortalization of human hepatocytes by temperature-sensitive SV40 large-T antigen,” In Vitro Cellular & Developmental Biology - Animal, vol. 37, no. 3, pp. 166–168, 2001. View at Publisher · View at Google Scholar
  37. N. Kobayashi, T. Kunieda, M. Sakaguchi et al., “Active expression of p21 facilitates differentiation of immortalized human hepatocytes,” Transplantation Proceedings, vol. 35, no. 1, pp. 433-434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Wege, H. T. le, M. S. Chui et al., “Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential,” Gastroenterology, vol. 124, no. 2, pp. 432–444, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. R. A. F. M. Chamuleau, T. Deurholt, and R. Hoekstra, “Which are the right cells to be used in a bioartificial liver?” Metabolic Brain Disease, vol. 20, no. 4, pp. 327–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Haker, S. Fuchs, J. Dierlamm, T. H. Brümmendorf, and H. Wege, “Absence of oncogenic transformation despite acquisition of cytogenetic aberrations in long-term cultured telomerase-immortalized human fetal hepatocytes,” Cancer Letters, vol. 256, no. 1, pp. 120–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Reid, J. P. Gaddipati, D. Yadav, and J. Kantor, “Establishment of a human neonatal hepatocyte cell line,” In Vitro Cellular & Developmental Biology - Animal, vol. 45, no. 9, pp. 535–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Chen, J. Li, X. Liu, W. Zhao, Y. Wang, and X. Wang, “Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice,” Transplantation Proceedings, vol. 42, no. 5, pp. 1907–1914, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Pan, J. Z. Li, W. B. du et al., “Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers,” Biotechnology Letters, vol. 34, no. 12, pp. 2183–2190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Y. Meng, L. Liu, F. H. Yang, C. Y. Li, J. Liu, and P. Zhou, “Reversible immortalization of human hepatocytes mediated by retroviral transfer and site-specific recombination,” World Journal of Gastroenterology, vol. 20, no. 36, pp. 13119–13126, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Salmon, J. Oberholzer, T. Occhiodoro, P. Morel, J. Lou, and D. Trono, “Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes,” Molecular Therapy, vol. 2, no. 4, pp. 404–414, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. T. H. Nguyen, G. Mai, P. Villiger et al., “Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes,” Journal of Hepatology, vol. 43, no. 6, pp. 1031–1037, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Tsuruga, T. Kiyono, M. Matsushita et al., “Effect of intrasplenic transplantation of immortalized human hepatocytes in the treatment of acetaminophen-induced acute liver failure SCID mice,” Transplantation Proceedings, vol. 40, no. 2, pp. 617–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Deurholt, N. P. van Til, A. A. Chhatta et al., “Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes,” BMC Biotechnology, vol. 9, no. 1, p. 89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. M. Cooper and S. Okenquist, “Mechanism of transfection of chicken embryo fibroblasts by Rous sarcoma virus DNA,” Journal of Virology, vol. 28, no. 1, pp. 45–52, 1978. View at Google Scholar
  50. P. F. Lewis and M. Emerman, “Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus,” Journal of Virology, vol. 68, no. 1, pp. 510–516, 1994. View at Google Scholar
  51. L. Naldini, U. Blomer, P. Gallay et al., “In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector,” Science, vol. 272, no. 5259, pp. 263–267, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. H. C. Huang, C. C. Chen, W. C. Chang, M. H. Tao, and C. Huang, “Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis,” Journal of Virology, vol. 86, no. 17, pp. 9443–9453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Ivics and Z. Izsvák, “The expanding universe of transposon technologies for gene and cell engineering,” Mobile DNA, vol. 1, no. 1, p. 25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. Z. Ivics, P. B. Hackett, R. H. Plasterk, and Z. Izsvák, “Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells,” Cell, vol. 91, no. 4, pp. 501–510, 1997. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Izsvák, E. E. Stüwe, D. Fiedler, A. Katzer, P. A. Jeggo, and Z. Ivics, “Healing the wounds inflicted by sleeping beauty transposition by double-strand break repair in mammalian somatic cells,” Molecular Cell, vol. 13, no. 2, pp. 279–290, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Izsvák and Z. Ivics, “Sleeping beauty transposition: biology and applications for molecular therapy,” Molecular Therapy, vol. 9, no. 2, pp. 147–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. M. H. Wilson, C. J. Coates, and A. L. George Jr., “PiggyBac transposon-mediated gene transfer in human cells,” Molecular Therapy, vol. 15, no. 1, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Kettlun, D. L. Galvan, A. L. George Jr., A. Kaja, and M. H. Wilson, “Manipulating piggyBac transposon chromosomal integration site selection in human cells,” Molecular Therapy, vol. 19, no. 9, pp. 1636–1644, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. E. Inada, I. Saitoh, S. Watanabe et al., “PiggyBac transposon-mediated gene delivery efficiently generates stable transfectants derived from cultured primary human deciduous tooth dental pulp cells (HDDPCs) and HDDPC-derived iPS cells,” International Journal of Oral Science, vol. 7, no. 3, pp. 144–154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Kim, I. M. Saadeldin, W. J. Choi et al., “Production of transgenic bovine cloned embryos using piggybac transposition,” Journal of Veterinary Medical Science, vol. 73, no. 11, pp. 1453–1457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. D. P. Bai, M. M. Yang, and Y. L. Chen, “PiggyBac transposon-mediated gene transfer in Cashmere goat fetal fibroblast cells,” Bioscience, Biotechnology and Biochemistry, vol. 76, no. 5, pp. 933–937, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. Wu, Z. Xu, X. Zou et al., “Pig transgenesis by piggyBac transposition in combination with somatic cell nuclear transfer,” Transgenic Research, vol. 22, no. 6, pp. 1107–1118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. Li, F. Zeng, F. Meng et al., “Generation of transgenic pigs by cytoplasmic injection of piggyBac transposase-based pmGENIE-3 plasmids,” Biology of Reproduction, vol. 90, no. 5, p. 93, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Li, X. Li, T. Li et al., “Genetic modification and screening in rat using haploid embryonic stem cells,” Cell Stem Cell, vol. 14, no. 3, pp. 404–414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Miura, H. Inoko, I. Inoue et al., “piggyBac-mediated generation of stable transfectants with surface human leukocyte antigen expression from a small number of cells,” Analytical Biochemistry, vol. 437, no. 1, pp. 29–31, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. S. C.-Y. Wu, Y. J. J. Meir, C. J. Coates et al., “piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 41, pp. 15008–15013, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. D. A. O'Brochta and P. W. Atkinson, “Transposable elements and gene transformation in non-drosophilid insects,” Insect Biochemistry and Molecular Biology, vol. 26, no. 8-9, pp. 739–753, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. A. M. Handler, “Use of the piggyBac transposon for germ-line transformation of insects,” Insect Biochemistry and Molecular Biology, vol. 32, no. 10, pp. 1211–1220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. B. S. Crabb, T. F. de Koning-Ward, and P. R. Gilson, “Toward forward genetic screens in malaria-causing parasites using the piggyBac transposon,” BMC Biology, vol. 9, no. 1, p. 21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Li, J. M. Zhang, X. Li et al., “A piggyBac transposon-based mutagenesis system for the fission yeast Schizosaccharomyces pombe,” Nucleic Acids Research, vol. 39, no. 6, p. e40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Nishizawa-Yokoi, M. Endo, N. Ohtsuki, H. Saika, and S. Toki, “Precision genome editing in plants via gene targeting and piggyBac-mediated marker excision,” The Plant Journal, vol. 81, no. 1, pp. 160–168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. R. Rad, L. Rad, W. Wang et al., “PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice,” Science, vol. 330, no. 6007, pp. 1104–1107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Woltjen, I. P. Michael, P. Mohseni et al., “piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells,” Nature, vol. 458, no. 7239, pp. 766–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni, and K. Woltjen, “Virus-free induction of pluripotency and subsequent excision of reprogramming factors,” Nature, vol. 458, no. 7239, pp. 771–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Yusa, R. Rad, J. Takeda, and A. Bradley, “Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon,” Nature Methods, vol. 6, no. 5, pp. 363–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Ding, X. Wu, G. Li, M. Han, Y. Zhuang, and T. Xu, “Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice,” Cell, vol. 122, no. 3, pp. 473–483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. M. A. Li, D. J. Turner, Z. Ning et al., “Mobilization of giant piggyBac transposons in the mouse genome,” Nucleic Acids Research, vol. 39, no. 22, article e148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. K. M. Kahlig, S. K. Saridey, A. Kaja, M. A. Daniels, A. L. George, and M. H. Wilson, “Multiplexed transposon-mediated stable gene transfer in human cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 4, pp. 1343–1348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Xie, L. Ye, J. C. Chang et al., “Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac,” Genome Research, vol. 24, no. 9, pp. 1526–1533, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. F. Chen, J. Rosiene, A. Che, A. Becker, and J. LoTurco, “Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling,” Development, vol. 142, no. 20, pp. 3601–3611, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. M. J. Fraser, T. Clszczon, T. Elick, and C. Bauser, “Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera,” Insect Molecular Biology, vol. 5, no. 2, pp. 141–151, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. C. A. Bauser, T. A. Elick, and M. J. Fraser, “Proteins from nuclear extracts of two lepidopteran cell lines recognize the ends of TTAA-specific transposons piggyBac and tagalong,” Insect Molecular Biology, vol. 8, no. 2, pp. 223–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Cadiñanos and A. Bradley, “Generation of an inducible and optimized piggyBac transposon system,” Nucleic Acids Research, vol. 35, no. 12, article e87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. W. Wang, C. Lin, D. Lu et al., “Chromosomal transposition of PiggyBac in mouse embryonic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 27, pp. 9290–9295, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. R. Mitra, J. Fain-Thornton, and N. L. Craig, “piggyBac can bypass DNA synthesis during cut and paste transposition,” The EMBO Journal, vol. 27, no. 7, pp. 1097–1109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. K. Otsu, K. Ito, T. Kuzumaki, and Y. Iuchi, “Differential regulation of liver-specific and ubiquitously-expressed genes in primary rat hepatocytes by the extracellular matrix,” Cellular Physiology and Biochemistry, vol. 11, no. 1, pp. 33–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. L. E. Woodard and M. H. Wilson, “piggyBac-ing models and new therapeutic strategies,” Trends in Biotechnology, vol. 33, no. 9, pp. 525–533, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. S. K. Saridey, L. Liu, J. E. Doherty et al., “PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer,” Molecular Therapy, vol. 17, no. 12, pp. 2115–2120, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. H. Nakanishi, Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida, “piggyBac transposon-mediated long-term gene expression in mice,” Molecular Therapy, vol. 18, no. 4, pp. 707–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. A. L. Cooney, B. K. Singh, and P. L. Sinn, “Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery,” Molecular Therapy, vol. 23, no. 4, pp. 667–674, 2015. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Sato, E. Inada, I. Saitoh et al., “Site-targeted non-viral gene delivery by direct DNA injection into the pancreatic parenchyma and subsequent in vivo electroporation in mice,” Biotechnology Journal, vol. 8, no. 11, pp. 1355–1361, 2013. View at Publisher · View at Google Scholar · View at Scopus
  92. F. Liu, Y. K. Song, and D. Liu, “Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA,” Gene Therapy, vol. 6, no. 7, pp. 1258–1266, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. G. Zhang, V. Budker, and J. A. Wolff, “High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA,” Human Gene Therapy, vol. 10, no. 10, pp. 1735–1737, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Nakamura, T. Maehara, S. Watanabe, M. Ishihara, and M. Sato, “Liver lobe and strain difference in gene expression after hydrodynamics-based gene delivery in mice,” Animal Biotechnology, vol. 26, no. 1, pp. 51–57, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Nakamura, M. Ishihara, S. Watanabe, N. Ando, M. Ohtsuka, and M. Sato, “Intravenous delivery of piggyBac transposons as a useful tool for liver-specific gene-switching,” International Journal of Molecular Sciences, vol. 19, no. 11, p. 3452, 2018. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Szkolnicka and D. C. Hay, “Concise review: advances in generating hepatocytes from pluripotent stem cells for translational medicine,” Stem Cells, vol. 34, no. 6, pp. 1421–1426, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. K. A. D'Amour, A. D. Agulnick, S. Eliazer, O. G. Kelly, E. Kroon, and E. E. Baetge, “Efficient differentiation of human embryonic stem cells to definitive endoderm,” Nature Biotechnology, vol. 23, no. 12, pp. 1534–1541, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. J. Cai, Y. Zhao, Y. Liu et al., “Directed differentiation of human embryonic stem cells into functional hepatic cells,” Hepatology, vol. 45, no. 5, pp. 1229–1239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. G. Brolén, L. Sivertsson, P. Björquist et al., “Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage,” Journal of Biotechnology, vol. 145, no. 3, pp. 284–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. S. Snykers, J. De Kock, V. Rogiers, and T. Vanhaecke, “In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art,” Stem Cells, vol. 27, no. 3, pp. 577–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Si-Tayeb, F. P. Lemaigre, and S. A. Duncan, “Organogenesis and development of the liver,” Developmental Cell, vol. 18, no. 2, pp. 175–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Nagamoto, K. Takayama, K. Ohashi et al., “Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure,” Journal of Hepatology, vol. 64, no. 5, pp. 1068–1075, 2016. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Diecke, S. M. Jung, J. Lee, and J. H. Ju, “Recent technological updates and clinical applications of induced pluripotent stem cells,” The Korean Journal of Internal Medicine, vol. 29, no. 5, pp. 547–557, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Tsuruga, T. Kiyono, M. Matsushita et al., “Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy,” Cell Transplantation, vol. 17, no. 9, pp. 1083–1094, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. J. Urschitz and S. Moisyadi, “Transpositional transgenesis with piggyBac,” Mobile Genetic Elements, vol. 3, no. 3, article e25167, 2013. View at Publisher · View at Google Scholar
  106. T. Totsugawa, C. Yong, J. D. Rivas-Carrillo et al., “Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination,” Journal of Hepatology, vol. 47, no. 1, pp. 74–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. H. Yoshino, K. Hashizume, and E. Kobayashi, “Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume,” Gene Therapy, vol. 13, no. 24, pp. 1696–1702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. J. W. Fabre, A. Grehan, M. Whitehorne et al., “Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava,” Gene Therapy, vol. 15, no. 6, pp. 452–462, 2008. View at Publisher · View at Google Scholar · View at Scopus